Animas® Corporation is proud to be part of the Johnson & Johnson Family of Diabetes Companies and shares the vision to create a world without limits for people with diabetes. At Animas, we offer a wide range of products, including the Animas® 2020 insulin pump and inset® infusion sets. Animas has been committed, since 1996, to addressing individual patient needs through the development of life-performance technology and customer service, live 24 hours a day, 7 days a week, 365 days a year.
Cellnovo Limited is an innovative medical device company based in London, UK. Cellnovo has developed and produced the world's first Mobile Diabetes Management System. With its novel technology platform, Cellnovo is committed to providing freedom and ease of use to people living with diabetes and to providing the healthcare professional a means to better manage a patient's disease. Cellnovo's technology platform benefits all constituencies; the patient, the provider and the payer, by enabling efficient insulin delivery and management, whilst also providing industry first mobile enabled connectivity and real-time event tracking. For further information, please visit www.cellnovo.com.
Bayer Diabetes Care is a global market leader in the field of blood glucose monitoring systems, with over 40 years experience in providing devices and test strips. Bayer's Contour, Contour Link, Contour USB and Didget blood glucose meters represent a variety of different blood glucose monitoring solutions for people with diabetes, all featuring No CodingTM technology to increase patients' confidence that results reflect true blood glucose levels. Bayer Diabetes Care is committed to supporting children and young people with diabetes, and the whole team are delighted to be involved with the UK Children with Diabetes Friends for Life conference again in 2011. To find out more about Bayer's blood glucose meters and support materials, visit www.bayerdiabetes.co.uk.
Roche Diagnostics, maker of ACCU-CHEK® products, is the world's leading producer of diagnostic systems. As a global leader in diabetes care, we are proud that ACCU-CHEK products are trusted by millions of people worldwide. There is an ACCU-CHEK blood glucose meter for every need and all ACCU-CHEK products are accurate, convenient, and easy to use. To learn more about ACCU-CHEK products, visit our website at accu-chek.co.uk. You can count on ACCU-CHEK to make living with diabetes a little easier. Roche Diagnostics, the maker of ACCU-CHEK products is proud to be the Silver Level Sponsor of UK Children with Diabetes Conference.
The Juvenile Diabetes Research Foundation International is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. Founded in 1970 by parents of children with type 1 diabetes, JDRF's mission is to find a cure for diabetes and its complications through the support of research. Over the years, JDRF has provided more than $1.4 billion in grants for diabetes research throughout the world. Through its web site and more than 100 locations worldwide, JDRF has developed a diverse support network for families and adults with a type 1 connection, including a number of personal peer-to-peer programs and a range of resources to benefit individuals and families during every stage of life with diabetes. JDRF is proud to partner with Children with Diabetes on this conference as a charity partner. For more information, visit the JDRF Web site at www.jdrf.ca or call 1-877-CURE-533.
[ Report | More Photos | Sponsors | Event Announcement ]
Last Updated: Thursday November 03, 2011 10:26:12
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.